Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely budesonide 160 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely budesonide 80 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely budesonide 80 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely budesonide 250 microgram/1 milliliter conventional release solution for inhalation (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely budesonide 250 microgram/1 milliliter conventional release solution for inhalation (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely budesonide 500 microgram/1 milliliter conventional release solution for inhalation (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely budesonide 500 microgram/1 milliliter conventional release solution for inhalation (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Budesonide 9 mg gastro-resistant oral granules sachet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Budesonide 9 mg gastro-resistant oral granules sachet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely budesonide 80 microgram and formoterol fumarate dihydrate 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely budesonide 80 microgram and formoterol fumarate dihydrate 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Budesonide 160 microgram and formoterol fumarate dihydrate 4.5 microgram/actuation powder for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Budesonide 160 microgram and formoterol fumarate dihydrate 4.5 microgram/actuation powder for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Budesonide 100 microgram and formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Budesonide 100 microgram and formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Budesonide 200 microgram and formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Budesonide 200 microgram and formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Budesonide 9 mg prolonged-release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Budesonide 9 mg prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Budesonide 250 microgram/mL and formoterol fumarate 10 microgram/mL suspension for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Budesonide (substance) |
Inferred relationship |
Some |
2 |
Budesonide 250 microgram/mL and formoterol fumarate 10 microgram/mL suspension for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Budesonide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely budesonide 500 microgram/1 milliliter and formoterol fumarate 10 microgram/1 milliliter conventional release suspension for inhalation (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Budesonide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely budesonide 500 microgram/1 milliliter and formoterol fumarate 10 microgram/1 milliliter conventional release suspension for inhalation (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Budesonide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely budesonide 400 microgram and formoterol fumarate dihydrate 6 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely budesonide 400 microgram and formoterol fumarate dihydrate 6 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Budesonide 500 microgram/mL suspension for nebulizer |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Budesonide 500 microgram/mL suspension for nebulizer |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Budesonide 250 microgram/mL suspension for nebulizer |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Budesonide 250 microgram/mL suspension for nebulizer |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely budesonide 3 milligram/1 each gastro-resistant and prolonged-release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely budesonide 3 milligram/1 each gastro-resistant and prolonged-release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Budesonide (substance) |
Inferred relationship |
Some |
1 |